Stepping into the pricing debate, FDA chief Scott Gottlieb proposes new reimbursement idea for antibiotics
In an attempt to make good on its promise to tackle the superbug problem, the FDA trotted out a new idea today that it hopes …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
